express scripts holding co (ESRX) Key Developments
Investors Reportedly Eyes Stake In Omnicare
Apr 30 15
Omnicare Inc. (NYSE:OCR) is drawing interest from potential buyers including Express Scripts Holding Company (NasdaqGS:ESRX) and CVS Health Corporation (NYSE:CVS), people with knowledge of the matter said. Initial bids for Omnicare, which has a market value of about $8.5 billion, are due in May, the people said, asking not to be identified discussing private information. Omnicare is working with Bank of America Corp. and Centerview Partners to explore options including a possible sale, the people said. Potential bidders also include Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) and McKesson Corporation (NYSE:MCK), the people said. For any of the potential buyers, Omnicare would offer a way to boost earnings and dividends, analysts have said. Omnicare climbed 1.8% to $87.98 at the close in New York. There is no certainty Omnicare will reach a deal with any of the bidders, one of the people cautioned. Representatives for CVS, Express Scripts, McKesson and Walgreens declined to comment. A representative for Omnicare declined to comment, while spokesmen for Bank of America and Centerview didn’t immediately respond to requests for comment.
Express Scripts Holding Co. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Second Quarter Ending June 2015 and Full Year Ending December 31, 2015
Apr 28 15
Express Scripts Holding Co. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, revenues were $24,899.6 million compared to $23,685.0 million a year ago. Income before income taxes was $715.5 million compared to $595.8 million a year ago. Net income was $447.1 million compared to $334.5 million a year ago. Net income attributable to company was $441.1 million or $0.60 diluted per share compared to $328.3 million or $0.42 diluted per share a year ago. Net cash flows provided by operating activities was $281.4 million compared to $454.0 million a year ago. Purchases of property and equipment were $48.3 million compared to $117.1 million a year ago. Adjusted EBITDA attributable to company was $1,512.1 million or $4.92 per share compared to $1,471.0 million or $4.60 per share a year ago. Diluted EPS attributable to company, adjusted was $1.10 compared to $0.99 a year ago. Adjusted net income attributable to company was $811.1 million compared to $779.2 million a year ago.
For the current quarter ending in June, the company expects its per-share earnings to range from $1.39 to $1.43, up 13% to 16% year-over-year. Adjusted claims expect to range from $310 million to $330 million.
The company narrowed its adjusted earnings per diluted share guidance from a range of $5.35 to $5.49 to a range of $5.37 to $5.47, which maintains the mid-point of $5.42. The new guidance range represents growth of 10% to 12% over 2014. The company anticipates full-year 2015 integration costs to be approximately $250.0 million, but the exact amount is indeterminable. The company is unable to include these charges in the list of GAAP items not included in guidance for 2015 full-year earnings per diluted share attributable to company, adjusted selling, general and administrative, adjusted EBITDA and adjusted EBITDA per adjusted claim or to provide a reconciliation to the corresponding GAAP measure. 2015 Adjusted EPS will exclude amortization of intangible assets per diluted share in the range of $1.52 to $1.56.
Express Scripts Holding Company Announces New Credit Agreement Credit Suisse AG and Citibank, N.A
Apr 28 15
On April 28, 2015, Express Scripts Holding Company entered into a credit agreement with Credit Suisse AG, as administrative agent, Citibank, N.A., as syndication agent, and the other lenders and agents named therein, providing for a five-year $2.0 billion revolving loan facility, a two-year $2.5 billion term loan and a five-year $3.0 billion term loan. The company used the proceeds to repay its previously existing term loan and to terminate the commitments under its existing revolving loan facility and indicated it currently intends to use approximately $5.5 billion of proceeds for an accelerated share repurchase program ("ASR") in the near term and the remaining proceeds for other general corporate purposes.
Express Scripts Closes Fort Worth Facility, 227 Workers Lose Jobs
Apr 27 15
Express Scripts has cut 227 jobs at a facility in the Fossil Creek business park. Employees at the facility, 5450 N. Riverside Dr., were told on April 22 and released the same day. They will be paid for 60 days and the facility will be fully vacated by the end of June. The closing is part of a nationwide consolidation of the company's front-end pharmacy operations, where prescriptions are submitted, following the 2012 merger with Medco Health Solutions.
Express Scripts Holding Company to Report Q1, 2015 Results on Apr 28, 2015
Apr 9 15
Express Scripts Holding Company announced that they will report Q1, 2015 results After-Market on Apr 28, 2015